CSJA:FRA
CSL ADR
€28.40
arrow_downward
-0.70%(-0.20) 1D
Nob 20, 8:06:08 AM GMT+1 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CSJA...
Buksan
€28.40
Mataas
€28.40
Mababa
€28.40
Mkt. cap
94.68B
Avg. na dami
1.00
Dami
0.00
Mataas nang 52-wk
€43.40
Mababa nang 52-wk
€12.70
Bilang ng mga empleyado
29K
Buksan
€28.40
Mataas
€28.40
Mababa
€28.40
Mkt. cap
94.68B
Avg. na dami
1.00
Dami
0.00
Mataas nang 52-wk
€43.40
Mababa nang 52-wk
€12.70
Bilang ng mga empleyado
29K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Kalkine
·
9 oras ang nakalipas
CSL Limited Buys Back 82,396 Shares on 19 November 2026 Under $1.15 Billion Program
Kalkine
·
1 araw ang nakalipas
CSL (ASX:CSL) Shares Gain 11% Over a Year. What Should Investors Watch in the Restructuring?
Kalkine
·
2 araw ang nakalipas
CSL Limited Buys Back 42,434 Shares on 17 November 2026 Under $1.15 Billion Program
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Tungkol sa CSL ADR
CEOPaul McKenzie
Mga Empleyado29K
Itinatag1916
HeadquartersMelbourne, Victoria, Australia
SektorHealth Care
Industriya-
Websitecsl.com